Free Float 85,94 %
Shares Float 31,96 M
Shares Outstanding 37,18 M
Cellivery Therapeutics, Inc.
Share · KR7268600004 (XKOS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Cellivery Therapeutics, Inc.
No Price
Share Float & Liquidity
Invested Funds
The following funds have invested in Cellivery Therapeutics, Inc.:
Fund | Vol. in million 98,27 | Percentage (%) 0,10 % |
Fund | Vol. in million 24,36 | Percentage (%) 0,0078 % |
Fund | Vol. in million 123,31 | Percentage (%) 0,0078 % |
Company Profile for Cellivery Therapeutics, Inc. Share
Cellivery Therapeutics, Inc. researches and develops therapeutic drugs for life-threatening lethal diseases, such as cancer, inflammation, metabolic, and neurodegenerative diseases. It develops small molecule, antibody, and vaccine drugs based on its Therapeutic molecule Systemic Delivery Technology. The company was founded in 2014 and is based in Seoul, South Korea.
Company Data
Name Cellivery Therapeutics, Inc.
Company Cellivery Therapeutics, Inc.
Website
http://www.cellivery.com
Primary Exchange 
KOSDAQ
KOSDAQ
ISIN KR7268600004
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Daewoong Jo
Market Capitalization 248 Mrd.
Country South Korea
Currency KRW
Employees 0,0 T
Address K·BIZ DMC Tower, 121-904 Seoul
IPO Date 2018-11-09
Stock Splits
| Date | Split |
|---|---|
| 25.07.2022 | 2:1 |
| 01.02.2021 | 2:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| KOSDAQ | 268600.KQ |
More Shares
Investors who hold Cellivery Therapeutics, Inc. also have the following shares in their portfolio:
